💊Registration of Clinical Study Information and Disclosure of Clinical Study Results and Clinical Study Data
Sumitomo Dainippon Pharma Co., Ltd. believes that it should appropriately disclose to relevant parties, including healthcare providers, patients and researchers, information about and results of clinical studies (clinical trials) sponsored by Sumitomo Dainippon Pharma, with the aim of providing greater transparency of such clinical study data and realizing the full value thereof for contributing to scientific advancement, promotion of innovation, and enhancement of public health. Based on this recognition, we consistently register information on clinical studies and appropriately disclose study results in compliance with relevant laws, regulatory requirements, and industry guidelines for each country. In addition to these measures, in April 2018, we began providing access to our clinical study data via the data disclosure portal site clinicalstudydatarequest.com. Through defined processes using this portal site, researchers from outside of the company can access and analyze the clinical study data, which has been anonymized to protect personal information in accordance with relevant laws and regulations.
http://www.ds-pharma.com/rd/clinical/clinical_study_data.html